Estás usando un navegador no soportado
Usar Internet Explorer está desaconsejado por problemas de seguridad. Para ver correctamente esta web, por favor use cualquier navegador moderno: Chrome, Firefox, Edge, Safari u otro de su elección.
En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias
FILTRAR POR:
2033 ARTÍCULOS , VIENDO DEL 1516 AL 1530
Recommendations to address key recruitment challenges of Alzheimer's disease clinical trials
Langbaum JB, Zissimopoulos J, Au R, Bose N, Edgar CJ, Ehrenberg E, Fillit H, Hill CV, Hughes L, Irizarry M, Kremen S, Lakdawalla D, Lynn N, Malzbender K, Maruyama T, Massett HA, Patel D, Peneva D, Reiman EM, Romero K, Routledge C, Weiner MW, Weninger S, Aisen PS.
Alzheimers Dement. 2023 Feb;19(2):696-707. doi: 10.1002/alz.12737. Epub 2022 Aug 10.
Autophagy Balances Neuroinflammation in Alzheimer's Disease
Cheng X, Wei Y, Qian Z, Han L.
Cell Mol Neurobiol. 2023 May;43(4):1537-1549. doi: 10.1007/s10571-022-01269-6. Epub 2022 Aug 12.
Natural remedies for Alzheimer's disease: A systematic review of randomized controlled trials
Ahmad S, Ahmed SB, Khan A, Wasim M, Tabassum S, Haider S, Ahmed F, Batool Z, Khaliq S, Rafiq H, Tikmani P, Gilani AU.
Metab Brain Dis. 2023 Jan;38(1):17-44. doi: 10.1007/s11011-022-01063-9. Epub 2022 Aug 12.
Pinpointing the locus of GABAergic vulnerability in Alzheimer's disease
Melgosa-Ecenarro L, Doostdar N, Radulescu CI, Jackson JS, Barnes SJ.
Semin Cell Dev Biol. 2023 Apr;139:35-54. doi: 10.1016/j.semcdb.2022.06.017. Epub 2022 Aug 10.
Aß Pathology and Neuron-Glia Interactions: A Synaptocentric View
Huffels CFM, Middeldorp J, Hol EM.
Neurochem Res. 2023 Apr;48(4):1026-1046. doi: 10.1007/s11064-022-03699-6. Epub 2022 Aug 17.
Saffron as a promising therapy for diabetes and Alzheimer's disease: mechanistic insights
Sanaie S, Nikanfar S, Kalekhane ZY, Azizi-Zeinalhajlou A, Sadigh-Eteghad S, Araj-Khodaei M, Ayati MH, Andalib S.
Metab Brain Dis. 2023 Jan;38(1):137-162. doi: 10.1007/s11011-022-01059-5. Epub 2022 Aug 20.
Neuroinflammation in Alzheimer's Disease: Current Progress in Molecular Signaling and Therapeutics
Thakur S, Dhapola R, Sarma P, Medhi B, Reddy DH.
Inflammation. 2023 Feb;46(1):1-17. doi: 10.1007/s10753-022-01721-1. Epub 2022 Aug 20.
Scrutinizing the Therapeutic Potential of PROTACs in the Management of Alzheimer's Disease
Bhatia S, Singh M, Singh T, Singh V.
Neurochem Res. 2023 Jan;48(1):13-25. doi: 10.1007/s11064-022-03722-w. Epub 2022 Aug 20.
Sharma B, Satija G, Madan A, Garg M, Alam MM, Shaquiquzzaman M, Khanna S, Tiwari P, Parvez S, Iqubal A, Haque SE, Khan MA.
Inflammation. 2023 Feb;46(1):56-87. doi: 10.1007/s10753-022-01730-0. Epub 2022 Aug 25.
Targeting Novel microRNAs in Developing Novel Alzheimer's Disease Treatments
Seyedaghamiri F, Rajabi M, Mohaddes G.
Neurochem Res. 2023 Jan;48(1):26-38. doi: 10.1007/s11064-022-03734-6. Epub 2022 Sep 1.
Inflammasome activation in traumatic brain injury and Alzheimer's disease
Johnson NH, de Rivero Vaccari JP, Bramlett HM, Keane RW, Dietrich WD.
Transl Res. 2023 Apr;254:1-12. doi: 10.1016/j.trsl.2022.08.014. Epub 2022 Sep 5.
Calcineurin Signalling in Astrocytes: From Pathology to Physiology and Control of Neuronal Functions
Lim D, Tapella L, Dematteis G, Talmon M, Genazzani AA.
Neurochem Res. 2023 Apr;48(4):1077-1090. doi: 10.1007/s11064-022-03744-4. Epub 2022 Sep 9.
George N, AbuKhader M, Al Balushi K, Al Sabahi B, Khan SA.
Nutr Neurosci. 2023 Oct;26(10):975-996. doi: 10.1080/1028415X.2022.2121092. Epub 2022 Sep 20.
Development of new Alzheimer's disease drug candidates using donepezil as a key model
Eissa KI, Kamel MM, Mohamed LW, Kassab AE.
Arch Pharm (Weinheim). 2023 Jan;356(1):e2200398. doi: 10.1002/ardp.202200398. Epub 2022 Sep 23.
Malter JS.
Transl Res. 2023 Apr;254:24-33. doi: 10.1016/j.trsl.2022.09.003. Epub 2022 Sep 23.
Actualización mensual Regístrese para recibir los avisos de actualización
Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.